The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study

Lymphoma

Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group

Lancet Haematol

Bazarbachi A, Fekom M, Martinez C, Khvedelidze I, Moukalled N, Peggs KS, Halahleh K, Bramanti S, Giebel S, Aljurf M, Sakellari I, Benakli M, Bonifazi F, Cerretti R, Devillier R, Kulagin A, Nicholson E, Forcade E, Walewski J, Tanase A, Sureda A

doi: 10.1016/S2352-3026(26)00169-9

Lymphoma

Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study

Br J Haematol

Porges T, Levi T, Dann EJ, Aumann S, Gurion R, Buchrits S, Perry C, Vitkon R, Levi I, Ilan E, Avigdor A, Marcus R, Harel R, Lahham N, Basood M, Filanovsky K, Dally N, Itchaki G, Sarid N, Benyamini N, Ben Barouch S, Tadmor T, Sofer O, Aboeid M, Strulovici A, Othman A, Kedmi M

doi: 10.1111/bjh.70682

Multiple Myeloma (MM)

REALiTEC: a multi-country observational retrospective study of teclistamab in patients with relapsed/refractory multiple myeloma outside of clinical trials

Haematologica

Uttervall K, Kortum MK, Perrot A, Farmer SL, Cavo M, Kishore B, Jacquet C, Casanova M, Hansson M, Weisel K, Magen H, Liberatore C, Hansen CT, Gatt ME, Shragai T, Da Via MC, Alvarez TS, Streetly M, Raab MS, Manier S, Aegesen J, Albrecht C, Hu P, Smirnov P, Santra D, Rubio-Azpeitia E, Popat R

doi: 10.3324/haematol.2025.289281

Breast Cancer

Clinical potential of whole-genome data linked to mortality statistics in patients with breast cancer in the UK: a retrospective analysis

Lancet Oncol

Black D, Davies HR, Koh GCC, Chmelova L, Cubric M, Chalivelaki Chan G, Degasperi A, Czarnecki J, Toong PJ, Memari Y, Whitworth J, Zhao SJ, Kumar Y, Basyuni S, Rinaldi G, Shooter S, Dembrovskyi V, Davies R, Chatzou Dunford M, Copson E, Palmieri C, Borg Å, Ambrose J, Bunce C, Sosinsky A, Arumugam P, Brown MA, Staaf J, Turner N, Nik-Zainal S

doi: 10.1016/S1470-2045(25)00400-0

Gastrointestinal Cancer

Patterns in genomic mutations among patients with early-onset colorectal cancer: an international, multicohort, observational study

Lancet Oncol

Li J, Pan Y, Guo F, Wang C, Liang L, Li P, Liang W, Lian P, Chen Y, Yang Y, Lin W, Li X, Perea J, Hendrickx WRL, Holowatyj AN, Guo X, Du L, Sinicrope FA, Ma Y

doi: 10.1016/S1470-2045(25)00239-6

Lymphoma

Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study

Blood Cancer J

Hamby M, Egleston BL, Frosch ZAK, Steiner RE, Noy A, Carvajal V, Chong ER, Tolu SS, Jean-Louis G, Amengual JE, Patel R, Ahmed S, Sharp J, Voorhees T, Baiocchi R, Ramirez-Gamero A, Castillo JJ, Hamburger E, Dittus C, Nizamuddin IA, Mehta-Shah N, Thaw Dar NN, Sandoval-Sus J, Rojek AE, Riedell PA, Khan N, Danilov A, Solipuram V, Rubinstein PG, Ariotti A, Suneja G, Vartanov A, Milrod C, Olszewski AJ, Smilnak G, Ayers E, Desai S, Rhodes JM, Magarelli G, Feldman T, Pellon M, Aboulafia DM, Bae W, Galvez C, Bhatlapenumarthi V, Hamadani M, Barta SK

doi: 10.1038/s41408-026-01457-3

Lymphoma

Outcomes of CAR T-Cell Therapy in transformed indolent Non-Hodgkin Lymphomas and de novo DLBCL: A comparative analysis from the Italian CAR T-SIE study

Eur J Cancer

Fabbri N, Casadei B, Chiappella A, Stella F, Donzelli L, Galli E, Riva M, Martino M, Barbui AM, Musso M, Farina M, Angelillo P, Cutini I, Santoro A, Cavallo F, Rivela P, Castellino A, Krampera M, Petruzzellis G, Grillo G, Argnani L, Bonifazi F, Corradini P, Zinzani PL

doi: 10.1016/j.ejca.2026.116879

Lymphoma

Radiotherapy may be omitted in children and adolescents with classical Hodgkin lymphoma in complete remission after frontline risk and response-adapted chemotherapy: a multicenter clinical trial (LH-GALOP 2017)

Leuk Lymphoma

Alfaro E, Schelotto M, Zamaro H, Sánchez La Rosa C, Guitter M, Romero C, Galluzzo L, Pinto N, Peruzzo L, Pages C, Nuñez F, Pennella C, Concha E, Tedesco E, Dabezies A, Castillo L, Felice MS, Zubizarreta P

doi: 10.1080/10428194.2026.2662496

Lymphoma

Haematopoietic stem cell transplantation in hepatosplenic T-cell lymphoma: a retrospective analysis of the EBMT Lymphoma Working Party

Lancet Haematol

Karsten IE, Schmitz N, Fekom M, Leval L, Khvedelidz I, Finel H, Kim WS, Wu D, Magnano L, Wang F, Huang XJ, Dreger P, Maertens J, Corradini P, Helbig G, Bethge W, Bacon CL, Vydra J, Balaguer-Roselló A, Stelljes M, Lenz G, Tanase A, Sureda A, Damaj G, Bazarbachi A, Glass B

doi: 10.1016/S2352-3026(26)00147-X

Related content

Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group

Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study

REALiTEC: a multi-country observational retrospective study of teclistamab in patients with relapsed/refractory multiple myeloma outside of clinical trials

Clinical potential of whole-genome data linked to mortality statistics in patients with breast cancer in the UK: a retrospective analysis

Patterns in genomic mutations among patients with early-onset colorectal cancer: an international, multicohort, observational study

Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study

Outcomes of CAR T-Cell Therapy in transformed indolent Non-Hodgkin Lymphomas and de novo DLBCL: A comparative analysis from the Italian CAR T-SIE study

Radiotherapy may be omitted in children and adolescents with classical Hodgkin lymphoma in complete remission after frontline risk and response-adapted chemotherapy: a multicenter clinical trial (LH-GALOP 2017)

Haematopoietic stem cell transplantation in hepatosplenic T-cell lymphoma: a retrospective analysis of the EBMT Lymphoma Working Party